Suchergebnisse - "Hosmane, Balakrishna"

PubPharm (38)

1

CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit : An Exploratory Analysis From the VELIA/GOG-3005 Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von You, B. | Sehgal, V. | Hosmane, B. | +12

ErratumIn: J Clin Oncol. 2023 Jan 25;:JCO2202888. - PMID 36696626

2

Drug response hysteresis in the concentration-QTc analysis of early clinical trials

enthalten in: Journal of biopharmaceutical statistics | 2021

von Li, H. | Tong, B. | Hosmane, B. | +1

3

Global Analysis of Models for Predicting Human Absorption : QSAR, In Vitro, and Preclinical Models

enthalten in: Journal of medicinal chemistry | 2021

von Price, E. | Kalvass, J. | DeGoey, D. | +3

4

Drug response hysteresis in the concentration-QTc analysis of early clinical trials

enthalten in: Journal of biopharmaceutical statistics | 2021

von Li, H. | Tong, B. | Hosmane, B. | +1

5

Use of Early Clinical Trial Data to Support Thorough QT Study Waiver for Upadacitinib and Utility of Food Effect to Demonstrate ECG Assay Sensitivity

enthalten in: Clinical pharmacology and therapeutics | 2018

von Mohamed, M. | Zeng, J. | Jiang, P. | +2

6

Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection

enthalten in: The AAPS journal | 2017

von Polepally, A. | Wang, H. | Marroum, P. | +8

7

Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection

enthalten in: The AAPS journal | 2017

von Polepally, A. | Wang, H. | Marroum, P. | +8

8

Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection

enthalten in: AAPS PharmSci | 2017

von Polepally, A. | Wang, H. | Marroum, P. | +8

9

Pharmacokinetic and exposure-response analyses of leuprolide following administration of leuprolide acetate 3-month depot formulations to children with central precocious puberty

enthalten in: Clinical drug investigation | 2014

von Mostafa, N. | Hosmane, B. | Larsen, L. | +3

10

Pharmacokinetic and Exposure–Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty

enthalten in: Clinical drug investigation | 2014

von Mostafa, N. | Hosmane, B. | Larsen, L. | +3